The primary aim of this study was not to evaluate treatment impact on tumor growth, as our previous study unsurprisingly showed no observable difference in volume at the imaging timepoint after Adv/GM-CSF treatment (Figure 3D) (25). The gene discussed is CSF2; the disease is neoplasm.